ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
0,00%
Dow Jones
38 589,16
-0,15%
DAX
18 020,49
0,00%
Brent Oil
81,895
-0,28%
Bitcoin
66 133,98
-0,76%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Verona Pharma Plc (VRP)

  7. Verona Pharma Plc (VRP) Actualités

VRP

Verona Pharma (VRP)

Verona Pharma Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:VRP
DateHeureSourceTitreSymboleSociété
02/02/202112h17UK RegulatoryVerona Pharma plc Correcting And Replacing -- Verona Pharma Reports Positive Phase 2 Results With Pmdi Formulation Of Ensifen...LSE:VRPVerona Pharma Plc
02/02/202108h00UK RegulatoryVerona Pharma plc Verona Pharma Reports Positive Phase 2 Results With Pmdi Formulation Of Ensifentrine In CopdLSE:VRPVerona Pharma Plc
14/01/202108h00UK RegulatoryVerona Pharma plc Verona Pharma Completes Enrollment In Pilot Study Of Pmdi Ensifentrine In U.S. Patients Hospitalized With C...LSE:VRPVerona Pharma Plc
05/01/202108h00UK RegulatoryVerona Pharma plc Verona Pharma To Present At H.C. Wainwright Virtualbioconnect ConferenceLSE:VRPVerona Pharma Plc
23/11/202008h00UK RegulatoryVerona Pharma plc Verona Pharma Secures Up To $30 Million Debt Financing From Silicon Valley BankLSE:VRPVerona Pharma Plc
09/11/202008h00UK RegulatoryVerona Pharma plc Verona Pharma Announces November 2020 Virtual Investor Conference ParticipationLSE:VRPVerona Pharma Plc
30/10/202008h00UK RegulatoryAIM Cancellation - Verona Pharma PLCLSE:VRPVerona Pharma Plc
29/10/202020h09Alliance NewsAlliance NewsIN BRIEF: Verona Pharma Says Third Quarter Loss WidensLSE:VRPVerona Pharma Plc
29/10/202008h00UK RegulatoryVerona Pharma plc Verona Pharma Plc Operational Update And Financial Results For The Three And Nine Months Ended September30,...LSE:VRPVerona Pharma Plc
28/10/202012h01UK RegulatoryVerona Pharma plc Verona Pharma Plc : Update On Aim DelistingLSE:VRPVerona Pharma Plc
23/10/202018h30UK RegulatoryFTSE Russell Verona PharmaLSE:VRPVerona Pharma Plc
22/10/202008h00UK RegulatoryVerona Pharma plc Verona Pharma To Announce Interim Results For The Three And Nine Months Ended September 30, 2020 And Provid...LSE:VRPVerona Pharma Plc
13/10/202008h00UK RegulatoryVerona Pharma plc Verona Pharma To Present Phase 2b Copd Symptom And Quality Of Life Data With Ensifentrine At Chest 2020LSE:VRPVerona Pharma Plc
23/09/202010h06UK RegulatoryVerona Pharma plc Verona Pharma Initiates Phase 3 Clinical Trials With Nebulized Ensifentrine For The Maintenance Treatment O...LSE:VRPVerona Pharma Plc
21/09/202015h12Alliance NewsAlliance NewsIN BRIEF: Verona Pharma To Delist From AIM But Remain On NasdaqLSE:VRPVerona Pharma Plc
21/09/202008h00UK RegulatoryVerona Pharma plc Intended Delisting And Cancellation Of Ordinary Shares From Trading On AimLSE:VRPVerona Pharma Plc
17/09/202008h00UK RegulatoryVerona Pharma plc Verona Pharma To Ring The Nasdaq Closing Bell To Celebrate $200 Million FinancingLSE:VRPVerona Pharma Plc
16/09/202014h25UK RegulatoryVerona Pharma plc Verona Pharma Announces Publication Of Phase 2b Copd Symptom Data In The International Journal Of Chronic O...LSE:VRPVerona Pharma Plc
08/09/202008h00UK RegulatoryVerona Pharma plc Verona Pharma Initiates Pilot Study With Pmdi Ensifentrine In U.S. Patients Hospitalized With Covid-19LSE:VRPVerona Pharma Plc
02/09/202008h00UK RegulatoryVerona Pharma plc Verona Pharma To Present At H.C. Wainwright 22nd Annual Global Virtual Investment ConferenceLSE:VRPVerona Pharma Plc
26/08/202011h19UK RegulatoryVerona Pharma plc Verona Pharma Plc: Grant Of Radsus And Pdmr DealingsLSE:VRPVerona Pharma Plc
24/08/202012h09Alliance NewsAlliance NewsVerona Pharma Says Study Shows Ensifentrine Improves Lung FunctionLSE:VRPVerona Pharma Plc
24/08/202008h00UK RegulatoryVerona Pharma plc Verona Pharma To Present Phase 2b Data With Ensifentrine In Copd At The European Respiratory Society Intern...LSE:VRPVerona Pharma Plc
19/08/202011h35Alliance NewsAlliance NewsVerona Pharma Makes Progress In Phase Two Of Inhaler Clinical TrialLSE:VRPVerona Pharma Plc
19/08/202008h00UK RegulatoryVerona Pharma plc Verona Pharma Initiates Multiple Dose Part Of Phase 2 Clinical Trial With Pmdi Formulation Of Ensifentrine ...LSE:VRPVerona Pharma Plc
14/08/202012h05UK RegulatoryVerona Pharma PLC Second Price Monitoring ExtnLSE:VRPVerona Pharma Plc
14/08/202012h00UK RegulatoryVerona Pharma PLC Price Monitoring ExtensionLSE:VRPVerona Pharma Plc
14/08/202010h22Alliance NewsAlliance NewsVerona To Trial Ensifentrine For Covid-19; First Half Loss WidensLSE:VRPVerona Pharma Plc
14/08/202008h00UK RegulatoryVerona Pharma plc Verona Pharma Plcoperational Update And Financial Results For The Three And Six Months Ended June30, 2020LSE:VRPVerona Pharma Plc
07/08/202016h46UK RegulatoryVerona Pharma plc Verona Pharma Plc: Tr-1: Standard Form For Notification Of Major HoldingsLSE:VRPVerona Pharma Plc
 Showing the most relevant articles for your search:LSE:VRP

Dernières Valeurs Consultées

BIT
S27206
Societe Generale Effekten
BOV
HYPE3
HYPERA ON
BIT
O8JNR4
Morgan Stanley Bv
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés